HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model.

Abstract
The anesthetized chronic AV-blocked dog (cAVB) and methoxamine-sensitized rabbit model are widely used to determine pro-arrhythmic properties of drugs. In general, both models show similar results. However, conflicting data have also been reported; K201 and AZD1305 induced Torsade de Pointes (TdP) exclusively in cAVB dogs. Vernakalant, an antiarrhythmic drug that blocks several ion channels has been approved only in Europe. Its propensity to induce repolarization-dependent TdP arrhythmias has been evaluated solely in the methoxamine-sensitized rabbits. We therefore assessed the proarrhythmic potential of vernakalant in the cAVB dog model. Vernakalant was evaluated in 10 mongrel dogs (sinus rhythm (SR) 2mg/kg; chronic AV block (cAVB) 2+3mg/kg). The same dogs were challenged with dofetilide (25 μg/kg) to evaluate TdP inducibility. During the serial experiments the animals were paced from the right ventricular apex (60 beats/min). Short-term variability of repolarization (STV) was quantified for proarrhythmic risk. In SR (n=8) vernakalant prolonged QT (265 ± 11 to 311 ± 18 ms P<0.01(**)) but not PQ or QRS. In cAVB (n=8), 2mg/kg vernakalant prolonged QT (391 ± 43 to 519 ± 73 ms(**)) and QRS (103 ± 24 to 108 ± 23 ms(**)). After a 30 min lag-time, 3mg/kg vernakalant (n=4) increased QT to a lesser extent (413 ± 34 to 454 ± 27 ms(**)) while maintaining QRS prolongation (114 ± 18 to 122 ± 20 ms(**)). Neither dose increased STV or caused arrhythmias. Dofetilide prolonged QT (398 ± 51 to 615 ± 71 ms(**)), increased STV (1.0 ± 0.4 to 2.2 ± 1.0 ms P<0.05(⁎)) and induced TdP arrhythmias in 6/8(⁎) cAVB dogs. Vernakalant did not induce arrhythmias in the cAVB dog model. Higher dosages (3mg/kg) did not prolong repolarization further whereas negative inotropic effects were starting to become apparent precluding further increases in dose.
AuthorsRosanne Varkevisser, Marcel A G van der Heyden, Ralph G Tieland, Jet D M Beekman, Marc A Vos
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 720 Issue 1-3 Pg. 49-54 (Nov 15 2013) ISSN: 1879-0712 [Electronic] Netherlands
PMID24211677 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 Published by Elsevier B.V.
Chemical References
  • Anisoles
  • Anti-Arrhythmia Agents
  • Phenethylamines
  • Pyrrolidines
  • Sulfonamides
  • vernakalant
  • dofetilide
Topics
  • Animals
  • Anisoles (pharmacology)
  • Anti-Arrhythmia Agents (adverse effects)
  • Atrioventricular Block (physiopathology)
  • Disease Models, Animal
  • Dogs
  • Female
  • Male
  • Phenethylamines (adverse effects)
  • Pyrrolidines (pharmacology)
  • Sulfonamides (adverse effects)
  • Torsades de Pointes (chemically induced, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: